Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,619 | 191 | 97.2% |
| Education | $105.81 | 2 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,388 | 61 | $0 (2024) |
| Janssen Biotech, Inc. | $709.42 | 64 | $0 (2024) |
| Amgen Inc. | $383.78 | 9 | $0 (2024) |
| GENZYME CORPORATION | $187.73 | 5 | $0 (2022) |
| Galderma Laboratories, L.P. | $177.12 | 8 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $137.49 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $113.16 | 6 | $0 (2022) |
| PFIZER INC. | $104.67 | 7 | $0 (2022) |
| Lilly USA, LLC | $85.14 | 4 | $0 (2024) |
| LEO Pharma Inc. | $82.32 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $696.73 | 51 | Janssen Biotech, Inc. ($409.23) |
| 2023 | $438.75 | 26 | Galderma Laboratories, L.P. ($177.12) |
| 2022 | $791.00 | 45 | ABBVIE INC. ($341.57) |
| 2021 | $422.70 | 27 | AbbVie Inc. ($223.07) |
| 2020 | $167.96 | 10 | AbbVie Inc. ($135.99) |
| 2019 | $397.63 | 9 | AbbVie, Inc. ($267.43) |
| 2018 | $284.87 | 13 | AbbVie, Inc. ($192.96) |
| 2017 | $525.21 | 12 | Amgen Inc. ($197.00) |
All Payment Transactions
193 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $32.42 | General |
| Category: Dermatology | ||||||
| 09/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: DERMATOLOGY | ||||||
| 09/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: Immunology | ||||||
| 08/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Immunology | ||||||
| 08/05/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Dermatology | ||||||
| 07/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $2.94 | General |
| Category: Immunology | ||||||
| 07/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Immunology | ||||||
| 07/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Dermatology | ||||||
| 07/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,030 | 2,160 | $273,900 | $85,199 |
| 2022 | 15 | 983 | 1,926 | $255,352 | $85,484 |
| 2021 | 14 | 702 | 1,328 | $173,353 | $59,843 |
| 2020 | 8 | 150 | 254 | $27,393 | $9,033 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 298 | $50,443 | $16,959 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 182 | $43,680 | $14,762 | 33.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 71 | 122 | $37,990 | $13,362 | 35.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 118 | 151 | $31,415 | $11,329 | 36.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 106 | 126 | $23,465 | $6,913 | 29.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 154 | 205 | $25,439 | $6,458 | 25.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 124 | 883 | $21,608 | $4,130 | 19.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 61 | 61 | $12,792 | $3,648 | 28.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 18 | 19 | $10,670 | $2,980 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $10,022 | $2,636 | 26.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 19 | 26 | $2,404 | $908.98 | 37.8% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 12 | 12 | $2,027 | $562.92 | 27.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 18 | $1,889 | $536.25 | 28.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 25 | $55.17 | $13.85 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 160 | 263 | $45,709 | $16,430 | 35.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 113 | 156 | $33,187 | $12,340 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 138 | $33,898 | $12,089 | 35.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 50 | 84 | $26,729 | $9,851 | 36.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 114 | 114 | $24,510 | $8,102 | 33.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 97 | 120 | $23,129 | $7,680 | 33.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 144 | 198 | $25,186 | $6,760 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $11,587 | $3,988 | 34.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 111 | 689 | $17,363 | $3,364 | 19.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 12 | 12 | $6,902 | $2,428 | 35.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 23 | 32 | $3,087 | $1,221 | 39.6% |
About Madelyn King
Madelyn King is a Dermatology healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2016. The National Provider Identifier (NPI) number assigned to this provider is 1811342124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Madelyn King has received a total of $3,725 in payments from pharmaceutical and medical device companies, with $696.73 received in 2024. These payments were reported across 193 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,619).
As a Medicare-enrolled provider, King has provided services to 2,865 Medicare beneficiaries, totaling 5,668 services with total Medicare billing of $239,559. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Mobile, AL
- Active Since 04/25/2016
- Last Updated 02/05/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1811342124
Products in Payments
- TREMFYA (Drug) $646.83
- Humira (Biological) $467.19
- SKYRIZI (Biological) $373.43
- Enbrel (Biological) $219.75
- HUMIRA (Biological) $216.49
- RINVOQ (Biological) $178.75
- DUPIXENT (Biological) $166.77
- DUPIXENT (Drug) $134.12
- Skyrizi (Biological) $132.14
- COSENTYX (Biological) $105.07
- REMICADE (Biological) $92.13
- EUCRISA (Drug) $76.96
- Otezla (Drug) $73.97
- OPZELURA (Drug) $70.73
- TALTZ (Drug) $59.73
- ADBRY (Biological) $49.70
- Tremfya (Drug) $36.79
- ENSTILAR (Drug) $32.62
- COSENTYX (Drug) $32.42
- Cimzia (Drug) $31.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Mobile
Dr. John Vanloock, M.d, M.D
Dermatology — Payments: $1.4M
Dr. Thomas Bender, Md, MD
Dermatology — Payments: $180,865
Kathryn Dempsey, M.d, M.D
Dermatology — Payments: $44,020
Dr. Ryan Ramagosa, M.d, M.D
Dermatology — Payments: $33,017
Virginia Reeder, M.d, M.D
Dermatology — Payments: $22,710
Aldo Trovato, Md, MD
Dermatology — Payments: $14,641